Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Ensign GroupFRA:EGB -0.10%90 Piotroski F-Score is 7 as of Aug. 19, 2026, which is 17% above its 10-year median of 6.00. GuruFocus rates FRA:EGB with a GF Score™ of 90/100 and a GF Value™ of €155.10 (Fairly Valued). The stock has 3 warning signs investors should review. Among 641 Healthcare Providers & Services companies, Ensign Group ranks better than 88.14% on this metric.
Good Sign:
Piotroski F-Score is 7, indicates a very healthy situation.
The zones of discrimination were as such:
Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3
Ensign Group has an F-score of 6 indicating the company's financial situation is typical for a stable company.
The historical rank and industry rank for Ensign Group's Piotroski F-Score or its related term are showing as below:
FRA:EGB'
s Piotroski F-Score Range Over the Past 10 Years
Min: 3 Med: 6 Max: 8
Current: 7
During the past 13 years, the highest Piotroski F-Score of Ensign Group was 8. The lowest was 3. And the median was 6.
Ensign Group (FRA:EGB) Piotroski F-Score Explanation
The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.
He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.
He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.
What he found was something that exceeded his most optimistic expectations.
Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.
Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).
Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.
Ensign Group Piotroski F-Score Related Terms
Ensign Group Piotroski F-Score Historical Data
* Premium members only.
The historical data trend for Ensign Group's Piotroski F-Score can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:EGB vs UHS, EHC, PACS: Piotroski F-Score Comparison
For the Medical Care Facilities subindustry, Ensign Group's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ensign Group Piotroski F-Score vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Ensign Group's Piotroski F-Score distribution charts can be found below:
* The bar in red indicates where Ensign Group's Piotroski F-Score falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.
Profitability
Question 1. Return on Assets (ROA)
Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.
Score 1 if positive, 0 if negative.
Ensign Group's current Net Income (TTM) was 326.
==> Positive ==> Score 1.
Question 2. Cash Flow Return on Assets (CFROA)
Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.
Ensign Group's return on assets of this year was 0.07620406. Ensign Group's return on assets of last year was 0.07136961.
==> This year is higher. ==> Score 1.
Question 4. Quality of Earnings (Accrual)
Compare Cash flow return on assets (2) to return on assets (1)
Ensign Group's gearing of this year was 0.39688868. Ensign Group's gearing of last year was 0.39077917.
==> Last year is lower than this year ==> Score 0.
Question 6. Change in Working Capital (Liquidity)
Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.
Score 1 if this year's current ratio is higher, 0 if it's lower
Ensign Group's current ratio of this year was 1.21099575. Ensign Group's current ratio of last year was 1.41248256.
==> Last year's current ratio is higher ==> Score 0.
Question 7. Change in Shares in Issue
Compare the number of shares in issue this year, to the number in issue last year.
Score 0 if there is larger number of shares in issue this year, 1 otherwise.
Ensign Group's number of shares in issue this year was 59.483. Ensign Group's number of shares in issue last year was 58.602.
==> There is larger number of shares in issue this year. ==> Score 0.
Efficiency
Question 8. Change in Gross Margin
Compare this year's gross margin (Gross Profit divided by sales) to last year's.
Score 1 if this year's gross margin is higher, 0 if it's lower.
Ensign Group's gross margin of this year was 0.16047625. Ensign Group's gross margin of last year was 0.15876206.
==> This year's gross margin is higher. ==> Score 1.
Question 9. Change in asset turnover
Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.
Score 1 if this year's asset turnover ratio is higher, 0 if it's lower
Ensign Group's asset turnover of this year was 1.10385696. Ensign Group's asset turnover of last year was 1.02019098.
==> This year's asset turnover is higher. ==> Score 1.
Evaluation
Piotroski F-Score
=
Que. 1
+
Que. 2
+
Que. 3
+
Que. 4
+
Que. 5
+
Que. 6
+
Que. 7
+
Que. 8
+
Que. 9
=
1
+
1
+
1
+
1
+
0
+
0
+
0
+
1
+
1
=
6
Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3
Ensign Group has an F-score of 6 indicating the company's financial situation is typical for a stable company.
Ensign Group (FRA:EGB) has a Piotroski F-Score of 7 as of Aug. 19, 2026. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Ensign Group and its competitors. This is 17% above median its historical median of 6.00. Over the past decade, Ensign Group's Piotroski F-Score has ranged from 3.00 to 8.00. According to the industry distribution chart, Ensign Group ranks #76 out of 641 companies in the Healthcare Providers & Services industry, placing it in the top 11.9%.
Is Ensign Group's Piotroski F-Score too high?
Ensign Group's current Piotroski F-Score of 7 is 17% above median its 10-year median of 6.00. Over the past 10 years, this metric has ranged from a low of 3.00 to a high of 8.00. The Healthcare Providers & Services industry median Piotroski F-Score is 5.00. Ensign Group's value of 7 is 40% above this industry median. Based on the distribution chart, Ensign Group ranks #76 out of 641 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Ensign Group has a GF Score™ of 90/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Ensign Group's Piotroski F-Score compare to UHS and EHC?
According to the Healthcare Providers & Services industry distribution chart, Ensign Group ranks #76 out of 641 companies for Piotroski F-Score. This places Ensign Group in the top 12% of its industry — outperforming the majority of peers. The industry median Piotroski F-Score is 5.00. Ensign Group's value of 7 is 40% above this benchmark. Historically, Ensign Group's own Piotroski F-Score has ranged from 3.00 to 8.00 over the past decade. While the company's 10-year median is 6.00 vs. the industry median of 5.00, Ensign Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Piotroski F-Score for a Healthcare Providers & Services company?
The median Piotroski F-Score among Healthcare Providers & Services companies is 5.00, based on 641 companies in the industry. Companies in the top quartile (top 25%) have a Piotroski F-Score significantly above this median, while those in the bottom quartile fall well below. However, Piotroski F-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ensign Group's current Piotroski F-Score of 7 is 40% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Piotroski F-Score mean?
A high Piotroski F-Score can signal that a stock is expensive relative to its fundamentals. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Ensign Group and its competitors. For the Healthcare Providers & Services industry, the median Piotroski F-Score is 5.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ensign Group's current Piotroski F-Score is 7, which is 17% above median its own 10-year median of 6.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ensign Group stock overvalued right now?
Based on GuruFocus' analysis, Ensign Group (FRA:EGB) is currently considered Fairly Valued. The stock's GF Value™ is €155.10, compared to a current price of €154.65 — trading 0.3% below its estimated fair value. The current Piotroski F-Score is 7, which is 17% above median its 10-year median of 6.00 and 40% above the Healthcare Providers & Services industry median of 5.00. Ensign Group's overall GF Score™ is 90/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Piotroski F-Score calculated?
Piotroski F-Score is calculated from a company's financial statements. For Ensign Group (FRA:EGB), the current Piotroski F-Score is 7 as of Aug. 19, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ensign Group (FRA:EGB) Overvalued in 2026?
Based on GuruFocus' analysis, Ensign Group stock appears to be undervalued.
The current stock price of €154.65 is trading 0.3% below its estimated GF Value™ of €155.10.
GuruFocus considers Ensign Group to be Fairly Valued.
Key valuation signals for FRA:EGB:
Piotroski F-Score: 7 (17% above median its 10-year median of 6.00)
GF Value™: €155.10 vs. price of €154.65 (0.3% below fair value)
Industry Position: 40% above the Healthcare Providers & Services median (#76 of 641)
No single metric tells the full story. See the FRA:EGB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ensign Group Inc provides post-acute healthcare services in the United States. Its regional subsidiaries oversee skilled nursing, assisted living, home health and hospice, mobile ancillary, and urgent care operations. Medicare and Medicaid programs contribute majority of revenue received for Ensign's services. The firm operates through two segments, Skilled services, and Standard Bearer. The skilled services segment includes the operation of skilled nursing facilities and rehabilitation therapy services. The Standard Bearer segment comprises of properties owned by the company through its captive REIT and leased to skilled nursing and assisted living operations. The majority of the revenue is generated from the skilled services segment.
90GF Score
Get the complete analysis for FRA:EGB
Piotroski F-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:EGB has been successfully added to your 
